{"id":"W2162805528","doi":"10.1056/nejmoa1215734","title":"Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2852,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Robarts Clinical Trials; Western University","funders":"Takeda Pharmaceuticals International","keywords":"Vedolizumab; Ulcerative colitis; Induction therapy; Maintenance therapy; Medicine; Internal medicine; Disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003516745,0.0004876844,0.001680684,0.0004233882,0.0002251079,0.0006725348,0.0009473364,0.0009434705,0.001949014],"category_scores_gemma":[0.002644946,0.0002324303,0.0006296326,0.0003385344,0.0007645842,0.0005805726,0.0003662495,0.001882308,0.0002835936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007249183,"about_ca_system_score_gemma":0.0007897622,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004440776,"about_ca_topic_score_gemma":0.0008718532,"domain_scores_codex":[0.9985518,0.0007742749,0.0001260002,0.0001711217,0.0002277967,0.0001490485],"domain_scores_gemma":[0.9981759,0.0007882928,0.0004506772,0.000123585,0.00006912921,0.0003925261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6429999,0.01527866,0.01426084,0.001716207,0.001436405,0.0001367745,0.0002020933,0.0009882187,0.0155428,0.0003857041,0.001131543,0.3059208],"study_design_scores_gemma":[0.5458283,0.3872789,0.05231682,0.000410772,0.001539064,0.000382993,0.00005444235,0.001712752,0.005619406,0.0002757214,0.00453194,0.00004884804],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9713839,0.02500984,0.0006104607,0.0005136336,0.0001574199,0.0007213374,0.0002240465,0.00006286287,0.00131654],"genre_scores_gemma":[0.9920768,0.004631969,0.001222149,0.0003774593,0.0002375591,0.0006515408,0.0003550624,0.000006622165,0.0004408594],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003516745,"threshold_uncertainty_score":0.01859856,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01002959855712218,"score_gpt":0.2578046912679587,"score_spread":0.2477750927108366,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}